Skip to main content
exlitem
Mark Goldin
Back to search
Mark Goldin

Mark Goldin

Mark Goldin, M.D. based in great neck, New York. specialization in Thrombosis, Deep vein thrombosis, Pulmonary embolism. Has testified 1 time and deposed 6 times.

M.D. ·

great neck, New York

About

Dr. Goldin is an experienced hospitalist and nationally recognized expert in thrombosis and anticoagulation. He is certified by the American Board of Internal Medicine and is a member of the Society of Hospital Medicine, where he holds the designation of Senior Fellow. He is also a Fellow of the American College of Physicians, underscoring his commitment to excellence in the field of internal medicine.

With over 13 years of experience as an attending physician at Long Island Jewish Medical Center, Dr. Goldin has honed his clinical skills in care of medical inpatients as well as surgical co-management. His expertise is widely recognized, and he has been invited to present at numerous regional, national, and international conferences and esteemed institutions, including McMaster University (Hamilton, ON, CA), the University of California, San Diego, and Università degli Studi dell'Insubria (Varese, Italy).

Dr. Goldin's scholarly contributions are equally impressive, with over 35 peer-reviewed publications in high-impact journals, including JAMA Internal Medicine and Circulation. He has served as an ad hoc reviewer for prestigious journals such as the JAMA and Journal of the American College of Cardiology. Additionally, Dr. Goldin has been involved in numerous clinical trials, further solidifying his reputation as a leading expert in his field.

With his extensive knowledge, clinical experience, and academic achievements, Dr. Mark Goldin is a highly credible and reliable expert witness in cases involving thrombosis, anticoagulation, and hospital medicine. His professionalism, attention to detail, and commitment to excellence make him an invaluable asset in legal proceedings requiring expert testimony.

Specialties

Thrombosis
Deep vein thrombosis
Pulmonary embolism
Anticoagulation
Surgical Co-management
Internal Medicine
Medical Informatics
Medical Malpractice
Health System Policy
Research
Electronic Health Record
Electronic Medical Record
Quality & Safety
Medical Education
Process Improvement
Venous thromboembolism
COVID-19 thromboprophylaxis
Reversal of critical bleeding in anticoagulated patients
Clinical decision support tools for thromboprophylaxis
Clinical trials
75
Cases Handled

Work Experience

Professor of MedicineCurrent
Zucker School of Medicine at Hofstra/Northwell, Northwell Health
Adjunct Clinical Assistant Professor of MedicineCurrent
Albert Einstein College of Medicine
Attending Physician, Hospital MedicineCurrent
Northwell Health

Education

MD in Internal Medicine
Albert Einstein College of Medicine
20092009
AB, cum laude in Biology with Honors
Harvard University
20052005
Residency in Internal Medicine
University of California, San Diego
20092012

Program Director: Elaine Muchmore

Physician Executive Leadership Development Program
Northwell Health
20232023
Mathematics of Machine Learning
Deeplearning.ai (Coursera)
20232023
Change Management
Northwell Health
20222022
Hospital Medicine Leadership Development Program
Northwell Health
20212021
Improvement Science Methodology
Northwell Health
20152015
Academic Hospitalist Academy
Society of Hospital Medicine
20132013

Credentials & Licenses

American Board of Internal Medicine
New York State Medical Board
California Medical Board

Expired

Expiry: 31 December 2012

MD

Albert Einstein College of Medicine

AB, cum laude

Harvard University

1
Times Testified
6
Times Deposed
75
Cases Worked
100:0
Plaintiff / Defendant

Publications

Clinical decision support tools to enhance thromboprophylaxis in order COVID-19 patients.
Society of Hospital Medicine
Reversal of Direct Oral Anticoagulants (DOACs) for Critical Bleeding or Urgent Procedures.
Journal of Clinical Medicine
Universal clinical decision support tool for thromboprophylaxis in hospitalized COVID-19 patients: post-hoc analysis of the IMPROVE-DD cluster randomized trial.
Journal of Thrombosis and Haemostasis
Clinical pathways and outcomes of andexanet alfa administration for reversal of critical bleeding in patients on oral direct factor Xa inhibitors.
TH Open
Universal EHRs Clinical Decision Support for Thromboprophylaxis in Medical Inpatients: A Cluster Randomized Trial.
JACC Advances
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.
Circulation
Rivaroxaban plus aspirin for extended thromboprophylaxis in acutely ill medical patients: insights from the MARINER trial.
TH Open
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
JAMA Internal Medicine
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
Journal of Thrombosis and Haemostasis
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry.
Blood
Thromboembolism Risk Profiles in Non-Valvular Atrial Fibrillation: How Can Machine Learning-Based Analysis Add to Our Understanding?
Journal of General Internal Medicine
Implementation of Hip Fracture Co-Management Program (AGS CoCare: Ortho®) in a Large Health System.
Journal of the American Geriatric Society
Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH.
Journal of Thrombosis and Haemostasis
Warfarin to direct or anticoagulants (DOACs) transition in eligible patients: a quality improvement initiative at a quaternary academic medical center.
Society of Hospital Medicine
Implementation of a Geriatrics-Focused Orthopaedic and Hospitalist Fracture Program Decreases Perioperative Complications and Improves Resource Utilization.
Journal of Orthopaedic Trauma

Professional Memberships

Society of Hospital Medicine
Professional society· Senior Fellow
Current
American College of Physicians
Professional society· Fellow
Current

Similar Verified Experts